Evaluation of factors affecting epidermal growth factor receptor tyrosine kinase inhibitor-induced hepatotoxicity in Japanese patients with non-small cell lung cancer: a two-center retrospective study

BACKGROUND: Gefitinib and erlotinib, are epidermal growth factor receptor tyrosine kinase inhibitors, and are currently recommended for non-small cell lung cancer stage IV in the elderly and in patients with decreased performance status in the Japanese Lung Cancer Society Guideline, but they occasio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagai, Hirofumi, Shimada, Tsutomu, Takahashi, Yoshimitsu, Nishikawa, Mikako, Tozuka, Hiroyuki, Yamamoto, Yasuto, Niwa, Osamu, Takahara, Yutaka, Fujita, Arimi, Nagase, Katsuhiko, Kasahara, Kazuo, Yano, Seiji, Sai, Yoshimichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714078/
https://www.ncbi.nlm.nih.gov/pubmed/36451213
http://dx.doi.org/10.1186/s40780-022-00258-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714078/
https://www.ncbi.nlm.nih.gov/pubmed/36451213
http://dx.doi.org/10.1186/s40780-022-00258-7

Ejemplares similares